HopeStage
Back to all studies
CompletedNCT02456896

Oxcarbazepine and BDNF Blood Levels in Bipolarity

About this titleRead the official source — NCT02456896
Medication studyAges 18–45India
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 45 years.

Listed locations
BhubaneswarSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2015
Recruitment status
Completed
Enrollment listed in the registry
50
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
India
Age range
From 18 Years to 45 Years
Official registry ID
NCT02456896
Official title
Show the full official title

Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bhubaneswar

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is All India Institute of Medical Sciences, Bhubaneswar, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Oxcarbazepine.

Who was this study for?

Listed age limits: 18 years to 45 years.

Want to explore more studies?

Explore studies